Cell and Gene Therapy, Industrial Impact

Asia Pacific Leads The Way In Cell & Gene Therapy Trials

December 16, 2022

Asia Pacific Leads
Cell and gene therapies (CGTs) are continuing to gain momentum in life sciences globally. However, Asia Pacific (APAC) has demonstrated the most growth in CGT
developers of any other region, with a rise of 10% in
H1 2022 compared to 2021.1

Spotlight

Advanced Testing Laboratory

Founded in 1987, ATL is a Scientific Sourcing Solutions Company. For more than 30 years, we’ve exceeded the highest expectations of the world’s most demanding customers in the Consumer Products, Pharmaceutical and Medical Device industries. ATL has become a recognized leader in creating innovative sourcing solutions across the entire product life cycle, from discovery through commercialization. Our services range from standard rules-based testing to operating and managing entire scientific functions.

OTHER WHITEPAPERS
news image

Osmolality monitoring for UF/DF and CEXcapture of mAbs from mammalian cell cultures

whitePaper | July 25, 2022

The goal of each process step is to facilitate the production of a consistent product with high yield, quality, purity, and functionality. Throughout each step various Process Analytical Tools (PAT) are used to ensure quality and production metrics are maintained.

Read More
news image

Biosimilars – commercial best practices in the age of sustainability

whitePaper | November 4, 2019

Revenues from biologics increased by 70% from 2011 to 2016. Biologics account for 20-22% of total pharmaceutical spending. IQVIA estimates US biologics spending will reach $320bn by 2023

Read More
news image

Risk assessment of fungal materials

whitePaper | February 24, 2022

Sustainable fungal materials have a high potential to replace non-sustainable materials such as those used for packaging or as an alternative for leather and textile.

Read More
news image

Imaweld® heat sealable & weldable tube bioprocess media

whitePaper | February 3, 2023

Imaweld® is thermoplastic elastomer tubing particularly designed to transfer critical fluid in pharmaceutical and biopharmaceutical applications.

Read More
news image

Producing therapeutic peptides using biotechnology

whitePaper | October 20, 2022

We began the project by working to the design of a recombinant bacterial strain selection of a strain capable of producing high concentrations of peptides.

Read More
news image

Liposomal and Nanoparticle Technology at Pfizer Melbourne

whitePaper | November 22, 2022

Specializing in oncology, anti-infective and complex formulations, Pfizer Melbourne provides end-to-end services from development through to commercial manufacture of sterile dosage forms.

Read More

Spotlight

Advanced Testing Laboratory

Founded in 1987, ATL is a Scientific Sourcing Solutions Company. For more than 30 years, we’ve exceeded the highest expectations of the world’s most demanding customers in the Consumer Products, Pharmaceutical and Medical Device industries. ATL has become a recognized leader in creating innovative sourcing solutions across the entire product life cycle, from discovery through commercialization. Our services range from standard rules-based testing to operating and managing entire scientific functions.

Events